Community Acquired Pneumonia
Community Acquired Pneumonia (CAP) is an infection of the lungs that you can catch outside of a healthcare setting, often caused by bacteria or viruses, leading to symptoms like cough, fever, and difficulty breathing.
We are studying whether trimodulin can improve survival in hospitalized adults with severe pneumonia compared to a placebo. The trial also looks at the safety and effects of the treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Community Acquired Pneumonia (CAP) is an infection of the lungs that you can catch outside of a healthcare setting, often caused by bacteria or viruses, leading to symptoms like cough, fever, and difficulty breathing.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.